These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18692938)

  • 1. Investigation of the incidence of "undesirable" molecular moieties for high-throughput screening compound libraries in marketed drug compounds.
    Axerio-Cilies P; Castañeda IP; Mirza A; Reynisson J
    Eur J Med Chem; 2009 Mar; 44(3):1128-34. PubMed ID: 18692938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bond stability of the "undesirable" heteroatom-heteroatom molecular moieties for high-throughput screening libraries.
    Yu B; Reynisson J
    Eur J Med Chem; 2011 Dec; 46(12):5833-7. PubMed ID: 22000918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of chemical libraries for their druggability.
    Sirois S; Hatzakis G; Wei D; Du Q; Chou KC
    Comput Biol Chem; 2005 Feb; 29(1):55-67. PubMed ID: 15680586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Known drug space as a metric in exploring the boundaries of drug-like chemical space.
    Mirza A; Desai R; Reynisson J
    Eur J Med Chem; 2009 Dec; 44(12):5006-11. PubMed ID: 19782440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
    Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
    Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the consistency of medicinal chemists in reviewing sets of compounds.
    Lajiness MS; Maggiora GM; Shanmugasundaram V
    J Med Chem; 2004 Sep; 47(20):4891-6. PubMed ID: 15369393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.
    Baell JB; Holloway GA
    J Med Chem; 2010 Apr; 53(7):2719-40. PubMed ID: 20131845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hit finding: towards 'smarter' approaches.
    Langer T; Hoffmann R; Bryant S; Lesur B
    Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New aspects of natural products in drug discovery.
    Lam KS
    Trends Microbiol; 2007 Jun; 15(6):279-89. PubMed ID: 17433686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissimilarity-based approaches to compound acquisition.
    Lajiness M; Watson I
    Curr Opin Chem Biol; 2008 Jun; 12(3):366-71. PubMed ID: 18423415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment-based ligand discovery.
    Fischer M; Hubbard RE
    Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topography-biased compound library design: the shape of things to come?
    Akritopoulou-Zanze I; Metz JT; Djuric SW
    Drug Discov Today; 2007 Nov; 12(21-22):948-52. PubMed ID: 17993413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput screening applied to drug synthesis process development.
    Cannarsa MJ; Uno T; Larsen C
    Curr Opin Drug Discov Devel; 2000 Nov; 3(6):743-9. PubMed ID: 19649902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multidimensional overpressured layer chromatographic method for the characterization of tetrazine libraries.
    Gombosuren N; Novák Z; Kotschy A; Mincsovics E; Dibó G
    J Biochem Biophys Methods; 2007 Jan; 69(3):239-49. PubMed ID: 16516973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
    Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian model averaging for ligand discovery.
    Angelopoulos N; Hadjiprocopis A; Walkinshaw MD
    J Chem Inf Model; 2009 Jun; 49(6):1547-57. PubMed ID: 19489531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer.
    Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA
    Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.